Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Announcement: 12 new world-class Speakers confirmed @ 2016 SharpBrains Virtual Summit (December 6-8th)

global_conversationWe’re honored to announce 12 new world-class speakers at the upcoming 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6-8th). More to come…this may well become the most diverse and stimulating brainstorming on the present and future of brain health and enhancement!

We can’t wait to hear from:

  • Alexandra Morehouse, CMO at Banner Health
  • Dr. Corey McCann, CEO of Pear Therapeutics
  • Dr. Gahan Pandina, Senior Director, Venture Leader at Janssen Research & Development
  • Dr. Judson Brewer, Founder & Research Lead of Claritas Mindsciences
  • Dr. Lara Boyd, Director of the Brain Behavior Lab at the University of British Columbia
  • Dr. Margaret Grabb, Chief of SBIR/STTR programs at the National Institute of Mental Health (NIMH)
  • Dr. Michael Merzenich, Winner of the 2016 Kavli Prize in Neuroscience
  • Nikhil Sri­ra­man, IP Analyst at SharpBrains
  • 2016sharpbrainssummit_logo

  • Richard Varn, Director of the Center for Advanced Technology and Neuroscience at Educational Testing Service (ETS)
  • Ron Riesenbach, Managing Director of the Canadian Centre for Aging and Brain Health Innovation (CC-ABHI)
  • Dr. Sandra Bond Chapman, Founder and Director, Center for BrainHealth at The University of Texas at Dallas
  • Tan Le, CEO of Emotiv

Google gets serious about brain & mental health innovation and hires NIMH Director Tom Insel

thomas-insel

.

NIH Director’s Statement Regarding Dr. Thomas Insel’s Departure:

“After serving 13 years as Director for the National Institute of Mental Health (NIMH), Thomas R. Insel, M.D., will step down effective November 1, 2015…he is definitely not retiring. He is planning to join the Google Life Sciences Read the rest of this entry »

Non-invasive neurotechnology: What’s next in research and clinical applications

Enjoy these great pre­sen­ta­tions on the future of non-invasive neurotech, deliv­ered at the 2014 Sharp­Brains Vir­tual Sum­mit and featuring:

  • Dr. Bruce Cuth­bert, Direc­tor of Adult Trans­la­tional Research and Treat­ment Devel­op­ment at the NIMH
  • Charles Fisher, Pres­i­dent of Fisher Wal­lace Laboratories
  • Chair: James Cavuoto, Edi­tor and Pub­lisher at Neu­rotech Reports

Dr. Thomas Insel, NIMH Director, to speak @ 2014 SharpBrains Virtual Summit

Tom InselWe are proud to share that Dr. Thomas Insel, Director of the National Institute of Mental Health and neurotechnology visionary, will open the 2014 SharpBrains Virtual Summit on Tuesday, October 28th.

Prior to this appoint­ment at NIMH, Dr. Insel was Pro­fes­sor of Psy­chi­a­try at Emory Uni­ver­sity, where he was found­ing direc­tor of the Cen­ter for Behav­ioral Neu­ro­science. He has pub­lished over 250 sci­en­tific arti­cles and four books, served on numer­ous aca­d­e­mic, sci­en­tific, and pro­fes­sional com­mit­tees and boards, and is a recip­i­ent of sev­eral awards, includ­ing the Out­stand­ing Ser­vice Award from the U.S. Pub­lic Health Ser­vice. Dr. Insel grad­u­ated from the com­bined B.A.-M.D. pro­gram at Boston Uni­ver­sity, did his intern­ship at Berk­shire Med­ical Cen­ter, Mass­a­chu­setts, and his res­i­dency at the Lan­g­ley Porter Neu­ropsy­chi­atric Insti­tute at the Uni­ver­sity of Cal­i­for­nia, San Francisco.

–> Explore the Agenda at 2014 SharpBrains Virtual Summit, and consider joining us October 28-30th!

Good profile of pioneer Dr. Thomas Insel, NIMH Director

ThomasInselBlazing Trails in Brain Science (The New York Times):

“The pendulum has swung so far toward drug therapy in recent years that it is hard to recapture how disruptive those 1980 studies were. Dr. Insel’s work and that of many others, testing the effect of new medications, would turn the field away from long-term talking cures and increasingly toward medication and short-term behavior therapies rooted in the same kind of randomized, controlled trials conducted in other fields of medicine…Yet the overall impact of this drug revolution on public health has been mixed…”

To Learn More:

Learn more & Register today at early-bird rates

2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age

About SharpBrains

As seen in The New York Times, The Wall Street Journal, CNN, and more, SharpBrains is an independent market research firm tracking applied brain science. Explore our most popular resources HERE.

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:
Join more than 50,000 Sub­scribers and stay informed and engaged.